Literature DB >> 29744793

Perceptions, opinions and knowledge of pharmacists towards the use of complementary medicines by people living with cancer.

Joanna Harnett1, Trong Quy Le2, Lorraine Smith2, Ines Krass2.   

Abstract

Background Biologically-based complementary medicine (BB-CM) use is prevalent amongst people living with cancer. Pharmacists play an important role in the provision of standard treatments for cancer. Less is known about pharmacist's provision of BB-CM information. Objective This study investigated the opinions, perceptions and knowledge of pharmacists regarding the use of BB-CMs by people living with cancer and the facilitators and barriers to providing information and advice. Setting Australia. Method A cross-sectional 53-item survey was developed and the survey link distributed in two professional associations newsletters. The associations represent ~29,000 pharmacists. Questions were categories into pharmacist's perceptions, opinions, and knowledge towards the use of BB-CM in cancer. Main Outcome Measure Scores obtained from responses to perception, opinion and knowledge statements and responses to demographic questions Results Respondents (n=70) were predominantly female (73%), Caucasian (66%) and under 40 years of age (78%). Respondents estimated that 19% of daily inquiries related to BB-CMs. Seventy-two per cent of respondents believed they had a responsibility to advise about the concomitant use of BB-CM with standard cancer treatments despite 60% reporting a lack of confidence in their knowledge. There was a moderate positive association (Spearman's rho 0.41 p= 0.001) between a pharmacists confidence in their level of knowledge and their total knowledge scores. The main barriers to providing information about BB-CMs reported were inadequate training in BB-CMs (94%) and reservations about the evidence base for efficacy and safety (50%). Conclusion Pharmacists have a role to play in counselling people living with cancer about their use of BB-CMs and this role could be maximized with further training and education in this area.

Entities:  

Keywords:  Australia; Cancer; Complementary medicines; Dietary supplements; Herbal medicines; Pharmacist’s knowledge; Pharmacist’s perceptions

Mesh:

Year:  2018        PMID: 29744793     DOI: 10.1007/s11096-018-0645-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


  31 in total

1.  Complementary and alternative medicine and critical care nurses: a survey of knowledge and practices in Australia.

Authors:  Marie Cooke; Marion Mitchell; Evelin Tiralongo; Jenny Murfield
Journal:  Aust Crit Care       Date:  2012-01-28       Impact factor: 2.737

2.  Low-dose dietary genistein negates the therapeutic effect of tamoxifen in athymic nude mice.

Authors:  Mengyuan Du; Xujuan Yang; James A Hartman; Paul S Cooke; Daniel R Doerge; Young H Ju; William G Helferich
Journal:  Carcinogenesis       Date:  2012-01-20       Impact factor: 4.944

3.  Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients.

Authors:  Lesley Braun; Jessica Harris; Paul Katris; Michael Cain; Haryana Dhillon; Bogda Koczwara; Ian Olver; Monica Robotin
Journal:  Asia Pac J Clin Oncol       Date:  2014-09-22       Impact factor: 2.601

Review 4.  Kidney toxicity related to herbs and dietary supplements: Online table of case reports. Part 3 of 5 series.

Authors:  Amy Christine Brown
Journal:  Food Chem Toxicol       Date:  2017-09       Impact factor: 6.023

Review 5.  Drug interactions with phytotherapeutics in oncology.

Authors:  Walter Emil Haefeli; Alexandra Carls
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-01-06       Impact factor: 4.481

Review 6.  Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.

Authors:  Kenneth A Conklin
Journal:  Integr Cancer Ther       Date:  2005-06       Impact factor: 3.279

7.  A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older.

Authors:  Tessa K Morgan; Margaret Williamson; Marie Pirotta; Kay Stewart; Stephen P Myers; Joanne Barnes
Journal:  Med J Aust       Date:  2012-01-16       Impact factor: 7.738

Review 8.  Ethical and legal issues at the interface of complementary and conventional medicine.

Authors:  Ian H Kerridge; John R McPhee
Journal:  Med J Aust       Date:  2004-08-02       Impact factor: 7.738

9.  [Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents].

Authors:  K Tsubaki; A Horiuchi; T Kitani; N Taniguchi; T Masaoka; H Shibata; T Yonezawa; T Tsubakio; H Kawagoe; Y Shinohara
Journal:  Gan To Kagaku Ryoho       Date:  1984-07

10.  Enhanced antitumor efficacy and counterfeited cardiotoxicity of combinatorial oral therapy using Doxorubicin- and Coenzyme Q10-liquid crystalline nanoparticles in comparison with intravenous Adriamycin.

Authors:  Nitin K Swarnakar; Kaushik Thanki; Sanyog Jain
Journal:  Nanomedicine       Date:  2014-03-15       Impact factor: 5.307

View more
  2 in total

Review 1.  Exploring Herbal Medicine Use during Palliative Cancer Care: The Integrative Physician as a Facilitator of Pharmacist-Patient-Oncologist Communication.

Authors:  Noah Samuels; Eran Ben-Arye
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-11

2.  Towards consensus: defining and supporting a professional role for pharmacists associated with traditional and complementary medicines - a protocol of implementing an international e-survey.

Authors:  Joanna E Harnett; Shane Desselle; Carolina Oi Lam Ung
Journal:  BMJ Open       Date:  2022-07-28       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.